PATENT CLAIM ANALYSIS

Application Number: 16094652
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "263400"]

Abstract:
The present disclosure relates to novel compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof; wherein R1, R2, Ra, Rb and Rc are as defined herein, pharmaceutical compositions containing same and methods for the treatment of cancer using same.

Claim (Index 11):
The compound of  claim 1 , or a pharmaceutically acceptable salt or solvate thereof; wherein each Ra is independently H, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, ter-butyl, trifluoromethyl, trifluoromethoxy, methoxy, or fluoride atom; Rb is H; Rc is H; R1 is an optionally substituted selenium-containing heterocycle of 5 or 6 or 7 members, an optionally substituted bridged bicycloalkyl of 7 members, an optionally substituted cycloalkyl of 6 or 7 carbon atoms or an optionally substituted heterocycle of 5 or 6 members; R2 is H.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.19512
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15160362', '14236852', '13700192', '14775449', '14317528']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75661664524836
- 35 USC 102 Novelty (BERT): 0.5225849092916005
- Combined Prediction Score: 0.733213471652684
- Mean Citation Score: 291.674494
- Max Citation Score: 304.20633
- Similarity Product: 229.48176411988376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test